Change over period: —
NSE · JSLL
JSLL
-61.7% from the 52-week high · +0.0% above the low
Jeena Sikho Lifecare Ltd. is an ayurveda based healthcare company which provides authentic and good quality ayurvedic products. The company is headquartered in Mohali, Punjab and currently employs 1,226 full-time employees. The company went IPO on 2022-04-19. The firm is engaged in developing health care products and providing ayurvedic healthcare services in India. The company has a portfolio of over a range of ayurvedic products. The Company’s products are manufactured under the brands, including Shuddhi, which provides ayurvedic herbs and products for almost all diseases; Origine Naturspired, which offers beauty and wellness products that help to nourish skin, hair, health, and face naturally. Its products include Shuddhi Kit, Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package and Shuddhi Divya Sanjeevani Anti-Viral. Its Shuddhi Kit offers a complete ayurvedic package that helps the human body in digestion, increases immunity, balances hormones, and helps in detoxification of the body. The firm also conducts various health checkup camps, yoga sessions free of charge to make people aware of their health problems.
The short version. JSLL reported revenue of ₹235 crore for Sep 2026, up 23.7% from a year earlier. Net profit was ₹37 crore (down 37.3% year on year). Return on equity was 47.5% in Mar 2026. Promoter holding was 63.67% in Sep 2026, up 0.14 points over 6 quarters.
1 · The price
How has the stock traded?
JSLL trades 61.7% below its 52-week high and 0.0% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹235 cr.
Sep 2026 net profit of ₹37 cr.
15.3 pts lower than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|---|---|
| Revenue | 235 | 224 | 216 | 222 | 190 | 174 |
| Net profit | 37 | 66 | 45 | 67 | 59 | 51 |
| Net margin % | 15.6 | 29.4 | 20.9 | 30.1 | 30.9 | 29.4 |
| EPS (₹) | 2.95 | 5.31 | 3.63 | 5.36 | 4.73 | 4.13 |
Annual
| FY2026 | FY2023 | |
|---|---|---|
| Revenue | 801 | 205 |
| Net profit | 222 | 34 |
| Net margin % | 27.7 | 16.5 |
| EPS (₹) | 17.85 | 0.0 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 47.5% in Mar 2026; debt to equity is 0.00.
Profitability · 3 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2023 | |
|---|---|---|---|
| Return on equity % | 47.5 | — | 26.9 |
| Return on capital % | 54.5 | — | 35.6 |
| EBITDA margin % | 44.2 | — | 23.2 |
| Net margin % | 27.4 | — | 16.3 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Up 0.14 pts over 6 quarters.
Down 1.49 pts over 6 quarters.
Up 0.35 pts over 6 quarters.
+2 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|
| Promoter | 63.53 | 63.61 | 63.62 | 63.62 | 63.62 | 63.67 | +0.14 |
| FII | 5.99 | 6.59 | 6.31 | 6.17 | 4.78 | 4.5 | -1.49 |
| DII | 0.18 | 0.15 | 0.11 | 0.46 | 0.36 | 0.53 | +0.35 |
| Public | 30.3 | 29.65 | 29.96 | 29.76 | 31.23 | 31.3 | +1.0 |
Mutual fund holdings · Oct 2026
6 schemes hold this stock
4 the month before.
- Motilal Oswal Nifty Microcap 250 Index Fund0.19% of NAV
- Bandhan Nifty Total Market Index Fund0.01% of NAV
- Groww Nifty Total Market Index Fund0.01% of NAV
- Angel One Nifty Total Market ETF0.01% of NAV
- Mirae Asset Nifty Total Market Index Fund0.01% of NAV
- Angel One Nifty Total Market Index Fund0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for JSLL are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about JSLL
What is the JSLL share price?
JSLL (JSLL) last closed at ₹303.25, up 2.33% on the day. Its 52-week range is ₹296.35 to ₹773.70.
What is the market cap of JSLL?
JSLL has a market capitalisation of about ₹3,684 crore. Its price-to-earnings ratio is 17.2.
How are JSLL's latest results?
JSLL reported revenue of ₹235 crore for Sep 2026, up 23.7% from a year earlier. Net profit was ₹37 crore (down 37.3% year on year). Return on equity was 47.5% in Mar 2026. Promoter holding was 63.67% in Sep 2026, up 0.14 points over 6 quarters.
Who owns JSLL?
As of Sep 2026, shareholding was: Promoter 63.67%, FII 4.5%, DII 0.53%, Public 31.3%.
How many mutual funds hold JSLL?
6 mutual fund schemes held JSLL in October 2026. That compares with 4 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 22 Sep 2025 · Final Dividend - Rs. 1.1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.